Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC.
Hosokawa M, Mikawa R, Hagiwara A, Okuno Y, Awaya T, Yamamoto Y, Takahashi S, Yamaki H, Osawa M, Setoguchi Y, Saito MK, Abe S, Hirai T, Gotoh S, Hagiwara M.
Hosokawa M, et al. Among authors: setoguchi y.
iScience. 2023 Aug 25;26(10):107731. doi: 10.1016/j.isci.2023.107731. eCollection 2023 Oct 20.
iScience. 2023.
PMID: 37701577
Free PMC article.